AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Year-over-year net income growth rate
Latest
6.87%
↑ 154% vs avg
Percentile
P79
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-12.70%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 6.87% |
| Q3 2025 | -44.74% |
| Q2 2025 | 39.32% |
| Q1 2025 | -41.57% |
| Q4 2024 | 40.99% |
| Q3 2024 | 11.69% |
| Q2 2024 | 13.13% |
| Q1 2024 | 1.66% |
| Q4 2023 | -1.14% |
| Q3 2023 | -5.71% |
| Q2 2023 | -3.14% |
| Q1 2023 | -29.40% |
| Q4 2022 | -4.44% |
| Q3 2022 | -12.05% |
| Q2 2022 | -32.20% |
| Q1 2022 | -1.46% |
| Q4 2021 | -8.67% |
| Q3 2021 | -38.67% |
| Q2 2021 | -144.48% |
| Q1 2021 | 0.00% |